What is NDC 70710-1899?

70710-1899 is the product NDC for Sitagliptin, Sitagliptin 25 mg/1 tablet, listed with the FDA by Zydus Pharmaceuticals (USA) Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals (USA) Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sitagliptin?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sitagliptin NDC 70710-1899 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1899Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1899Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1899-3	7071018990370710189903	30 TABLET in 1 BOTTLE (70710-1899-3)Marketed from Nov 30, 2023
70710-1899-9	7071018990970710189909	90 TABLET in 1 BOTTLE (70710-1899-9)Marketed from Nov 30, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sitagliptin
Generic name (nonproprietary): sitagliptin
Active ingredients: Sitagliptin — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Pharmaceuticals (USA) Inc.NDC labeler code 70710
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 211566
Marketing start: Nov 30, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Dipeptidyl Peptidase 4 Inhibitors (Mechanism)
Identifiers: Product ID 70710-1899_c489d9fa-c7f0-473f-9f7b-77086e137e8fSPL ID c489d9fa-c7f0-473f-9f7b-77086e137e8fSPL set ID 6a970e80-b753-48fa-9fff-87e7a5044982RxCUI 665033, 665038, 665042UNII QFP0P1DV7ZUPC 0370710190095
Pharmacologic class: Dipeptidyl Peptidase 4 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710189903 followed by a unit qualifier and the quantity

Package 70710-1899-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2025.

Indications (excerpt from the label)

Sitagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Sitagliptin Tablets is not recommended in patients with type 1 diabetes mellitus. Sitagliptin Tablets have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin Tablets. [see Warnings and Precautions (5.1) ]. Sitagliptin Tablets are a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70710-1899

What is NDC 70710-1899?: 70710-1899 is the product NDC for Sitagliptin, Sitagliptin 25 mg/1 tablet, listed with the FDA by Zydus Pharmaceuticals (USA) Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sitagliptin.
What is the active ingredient?: Sitagliptin.
Who is the labeler?: Zydus Pharmaceuticals (USA) Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sitagliptin?: 14 other product NDCs are listed under this name. See all Sitagliptin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sitagliptin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-2607	00480-2607-5600480-2607-98
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-2608	00480-2608-5600480-2608-98
Sitagliptin	Sitagliptin phosphate 100 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-2609	00480-2609-1000480-2609-5600480-2609-98
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Apotex Corp.	60505-3643	60505-3643-0360505-3643-09
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Apotex Corp.	60505-3644	60505-3644-0360505-3644-09
Sitagliptin	Sitagliptin phosphate 100 mg/1	Tablet, Film coatedOral	Apotex Corp.	60505-3645	60505-3645-0360505-3645-09
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-049	84677-0049-3084677-0049-90
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-050	84677-0050-90
Sitagliptin	Sitagliptin phosphate 100 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-051	84677-0051-3084677-0051-90
Sitagliptin	Sitagliptin 50 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1900	70710-1900-0370710-1900-09

All 15 Sitagliptin NDCs

Other NDCs under NDA 211566

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 211566
Product	Strength	Form · route	Labeler	Product NDC
Sitagliptin	Sitagliptin 50 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1900
Sitagliptin	Sitagliptin 100 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1901
Sitagliptin	Sitagliptin 25 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1790
Sitagliptin	Sitagliptin 50 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1791
Sitagliptin	Sitagliptin 100 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1792
Zituviositagliptin	Sitagliptin 25 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1240
Zituviositagliptin	Sitagliptin 50 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1241
Zituviositagliptin	Sitagliptin 100 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1242
Zituviositagliptin	Sitagliptin 25 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1770
Zituviositagliptin	Sitagliptin 50 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1771
Zituviositagliptin	Sitagliptin 100 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1772